This rapid recurrence after inhibition of oncogenic K-RAS was observed previously in a mouse lung cancer model in which tumors initially responded to knockdown of oncogenic K-Ras but recurred after 2 weeks with secondary oncogene activation [8]. The gene discussed is KRAS; the disease is lung carcinoma.